Does CareDx (CDNA) Have the Potential to Rally 42.25% as Wall Street Analysts Expect?

Group 1 - CareDx (CDNA) closed at $23.10, with a 1.7% gain over the past four weeks, and a mean price target of $32.86 indicating a 42.3% upside potential [1] - The average price targets range from a low of $24 to a high of $40, with a standard deviation of $6.39, suggesting variability in analyst estimates [2] - Analysts show strong agreement in revising earnings estimates higher, with a 21.9% increase in the Zacks Consensus Estimate for the current year [10][11] Group 2 - The consensus price target is often questioned for its reliability, as empirical research indicates that it rarely predicts actual stock price movements [5][6] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price direction [7] - CDNA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [11][12]